Gaucher's disease is a genetic disorder that causes a fatty tissue to build up in certain organs, especially the liver and spleen. The fatty substances cause the organs to become enlarged and affect their function.

Researchers at the IIBR say two drugs used to treat Gaucher's disease appear to inhibit viruses. The first drug is Cerdelga, which has already been approved by the US Food and Drug Administration. The second is Venglustat, which is in the process of being approved. 

The scientists found that together, the drugs led to "a significant reduction in the replication capacity of the corona virus and to the destruction of the infected cell," the Defense Ministry Spokesperson said in a statement.

"The two drugs under development are currently being tested for their effectiveness in treating animals infected with the Corona virus," the spokesperson continued.

The treatment was also found to be effective against three other viruses, the West Nile virus, Influenza A virus, and the Neuroinvasive Sindbis virus.

"This indicates their potential in treating various viral diseases effectively—including future outbreaks of new viruses—once they are clinically approved," the ministry wrote.

The researchers believe the drugs could be a temporary treatment for the coronavirus while scientists continue to work on a vaccine and treatment.

"Treatment of a new disease such as COVID-19 using an existing, approved drug may serve as an effective short-term solution considering that one of the major challenges in addressing such a pandemic is the length of time it takes for both the research and approval phases of new drugs," the ministry said.

The IIBR has been heavily involved in COVID-10 research.

Earlier this month, it announced that it had discovered a specific antibody that neutralizes the coronavirus. The institute also claimed it has completed a successful coronavirus vaccine trial on rodents. Subscribe for free to Breaking Christian News here

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Street Preacher's Arrest in Mississippi Sparks Supreme Court Case on Free Speech Rights

Trump Offers Plan for Healthcare Cost Crisis, GOP Senator Vows 'We're Going to Fix Obamacare'

Nigerian Persecution Horror: Expert Dismantles Disturbing Media Narrative

Man Dies on Operating Table, Meets Jesus, Sees Heaven; Stunned Doctor Says: 'God's Not Done with You'

Florida Moves to Redistrict in Congressional Maps Arms Race

Maduro's Ex-Insider Turns Whistleblower, Sends President Trump an Explosive Letter

Experts Warn Parents AI Christmas Toys Put Kids at Risk: 'Trouble in Toyland' [Video]

Pete Hegseth to Bring Christmas Back to the Pentagon: Blaze Exclusive

Iryna's Law Needs to Be Replicated Around the Country

Navy Admiral Set to Testify on Capitol Hill About Drug Boat Strike in Caribbean That Killed Survivors

DOJ: University of Delaware Student Allegedly Plotted Attack on Campus Police; Illegal Weapons Recovered

'Unbelievable Revival': God Is Moving with Power in Transnistria Despite Russia's Heavy Hand [Video]

Putin Calls Witkoff's Ukraine Peace Talks 'Difficult', Consensus 'No Easy Feat'

J6 Pipe Bomber Identified and Arrested

Warning: Pfizer's mRNA Flu Shot Linked to Very Serious Side Effects, Especially in Seniors

Ex-Muslim Leads 100,000 to Jesus: 'There Is Hunger in the Muslim World to Hear About Christ'

UNCOVERED: Hamas' Strategy to Infiltrate, Control NGOs in Gaza

Secretary Hegseth Considers Breaking with Woke Scouts after Longtime Pentagon Partnership

Rep. Harris Introduces Bill to Stop Discrimination against Homeschoolers

Bessent Moves to Completely Cut Off Illegals from US Financial System